Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Debt to Equity: 2011-2022

Historic Debt to Equity for Fennec Pharmaceuticals (FENC) over the last 8 years, with Sep 2022 value amounting to $8.92.

  • Fennec Pharmaceuticals' Debt to Equity was N/A to $8.92 in Q3 2022 from the same period last year, while for Sep 2022 it was $8.92, marking a year-over-year change of. This contributed to the annual value of $6.24 for FY2017, which is 67420.14% up from last year.
  • As of Q3 2022, Fennec Pharmaceuticals' Debt to Equity stood at $8.92, which was up 1,424.09% from $0.59 recorded in Q2 2022.
  • Fennec Pharmaceuticals' 5-year Debt to Equity high stood at $8.92 for Q3 2022, and its period low was $0.40 during Q1 2022.
  • Over the past 1 years, Fennec Pharmaceuticals' median Debt to Equity value was $0.59 (recorded in 2022), while the average stood at $3.30.